News

Home / News

TSH Biopharm was invited to attend the online institutional investor conference hosted by JihSun Securities

TSH Biopharm was invited to attend the online institutional investor conference hosted by JihSun Securities

2021.12.17

...

More

 Announcement of the Company's Acquisition of the Right-of-Use Assets From A Related Party

Announcement of the Company's Acquisition of the Right-of-Use Assets From A Related Party

2021.12.17 Change the scope of the lease, and the amount of the right-of-use asset

...

More

TSH Board of Directors Approved Financial Statements For the Nine Months Ended September 30, 2021

TSH Board of Directors Approved Financial Statements For the Nine Months Ended September 30, 2021

2021.11.3

...

More

In reponse to report of Commercial Times on Oct. 24, 2021

In reponse to report of Commercial Times on Oct. 24, 2021

2021.10.25

...

More

TSH's new combo new drug has been approved and expect to get NHI price in Q2,2022. Its potentional market is approximately 2.8

TSH's new combo new drug has been approved and expect to get NHI price in Q2,2022. Its potentional market is approximately 2.8

2021.10.20

...

More

TSH Biopharm was invited to attend the  online institutional investor conference hosted by IBF Securities

TSH Biopharm was invited to attend the online institutional investor conference hosted by IBF Securities

2021.9.27

...

More